ArticleScientific reports2025
BCDCNN: breast cancer deep convolutional neural network for breast cancer detection using MRI images.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fusion of genomic and pathological data for breast cancer detection using BCDNN.Frontiers in medicine · 2026Article
- Preoperative Breast MRI and Histopathology in Breast Cancer: Concordance, Challenges and Emerging Role of CEM and mpMRI.Diagnostics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer (BC) is a kind of cancer that is created from the cells in breast tissue. This is a primary cancer that occurs in women. Earlier identification of BC is significant in the treatment process. To lessen unwanted biopsies, Magnetic Resonance Imaging (MRI) is utilized for diagnosing BC nowadays. MRI is the most recommended examination to detect and monitor BC and explain lesion areas as it has a better ability for soft tissue imaging. Even though, it is a time-consuming procedure and requires skilled radiologists. Here, Breast Cancer Deep Convolutional Neural Network (BCDCNN) is presented for Breast Cancer Detection (BCD) using MRI images. At first, the input image is taken from the database and subjected to a pre-processing segment. Adaptive Kalman filter (AKF) is utilized to execute the pre-processing phase. Thereafter, cancer area segmentation is conducted on filtered images by Pyramid Scene Parsing Network (PSPNet). To improve segmentation accuracy and adapt to complex tumor boundaries, PSPNet is optimized using the Jellyfish Search Optimizer (JSO). It is a recent nature-inspired metaheuristic that converges to an optimal solution in fewer iterations compared to conventional methods. Then, image augmentation is performed that includes augmentation techniques namely rotation, random erasing and slipping. Afterwards, feature extraction is done and finally, BCD is conducted employing BCDCNN, wherein the loss function is newly designed based on an adaptive error similarity. It improves the overall performance by dynamically emphasizing samples with ambiguous predictions, enabling the model to focus more on diagnostically challenging cases and enhancing its discriminative capability. Furthermore, BCDCNN acquired 90.2% of accuracy, 90.6% of sensitivity and 90.9% of specificity. The proposed method not only demonstrates strong classification performance but also holds promising potential for real-world clinical application in early and accurate breast cancer diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.